908 Devices completed the acquisition of RedWave Technology for $76.2m.

908 Devices, a provider of purpose-built handheld and desktop mass spec devices for chemical and biochemical analysis, completed the acquisition of RedWave Technology, a provider of portable FTIR spectroscopic analyzers for rapid chemical identification of bulk materials for $76.2m. “We’re thrilled to welcome the RedWave team to 908 Devices. Our technology platforms are complementary as our forensics customers rely on both mass spec and FTIR analyzers to rapidly assess and monitor their environment for dangerous trace chemicals and bulk chemical hazards. RedWave Technology is a high growth and profitable company with innovative products that can immediately leverage our sales channel. RedWave is a strong fit and enables us to accelerate our strategic objectives,” Kevin J. Knopp, 908 Devices CEO and Co-founder.